Lupin founder-chairman Desh Bandhu Gupta dies at 79
27 June 2017
Lupin gets US FDA nod for marketing generic Percocet tablets
28 February 2017
Lupin, BC Partners shortlisted for Bayerís $1.1 bn dermatology business
14 October 2016
Lupin Indiaís most reputed drug brand; Sun, Cipla follow
18 August 2016
Lupin to buy 21 brands from Japanís Shionogi for $150 mn
02 August 2016
Lupin told to sell two drugs for getting regulatory nod for Gavis acquisition
20 February 2016
Lupin buys US generics drug maker Gavis for $880 mn
23 July 2015
USFDA approves Lupinís plant and product, raises concern over process
23 February 2015
Govt hikes FDI limit in HDFC Bank, Lupin; opens $2.6 bn investment window
29 January 2015
3 Indian firms get FDA nod to sell generic hypertension drug
07 January 2015
Lupin ties up with Salix to sell US firmís drugs in Canada
13 September 2014
Lupin in pact with Japanís Yoshindo to set up joint venture `YL Biologicsí
23 April 2014
Lupin recalls Suprax drug from US market after failing to meet US purity test
15 April 2014
Lupin to buy Mexican eye-treatments maker Laboratorios Grin
27 March 2014
Lupin acquires Dutch injectable company Nanomi BV
04 February 2014
Pfizer files patent-infringement suits against Lupin, four others
06 March 2013
Lupin receives US FDA approval for generic diabetic drug
05 July 2012
Lupin Q4 net slightly up at Rs249 crore
10 May 2012
Lupinís Q3 net rises nearly 5 per cent to Rs235 crore
24 January 2012
Lupin to acquire Japanís I'rom Pharmaceutical
17 November 2011
Lupin, Sanofi-Aventis Philippines in strategic agreement
05 September 2011
Eli Lilly ties up with Lupin to push diabetes drug sales
29 July 2011
Jhunjhunwala reduces stake in Lupin
20 July 2011
Lupin promoters to sell domestic operations: unconfirmed reports
18 July 2011
Lupin signs agreement with Abott Laboratories and others for Fenofibrate
27 April 2011
Lupin in pact to supply TB drug to Brazil
05 January 2011
Lupin net profit up 40 per cent in Q4
05 May 2010
Lupinís sleep disorder drug gets USFDA nod
22 March 2010
Lupin receives US FDA approval for perindopril erbumine tablets
29 January 2010
Lupin settles dispute with Forest Labs over Namenda
22 December 2009
Impressive Q2 results see Lupin net surge 38 per cent to Rs160 crore
27 October 2009
Lupin buys US rights for cholesterol drug Antara
29 September 2009
Lupin announces acquisition of worldwide rights for its nasal spray, AllerNaze
01 July 2009
Lupin reaches settlement with Wyeth on patented drug
13 May 2009
Pfizer brings patent infringement suits against Sun, Lupin, Wockhardt
06 May 2009
Divakar Kaza rejoins Lupin as president, HR
12 December 2008
Eli Lilly sues Lupin, Aurobindo for patent infringement
03 December 2008
US FDA observations not to affect drug sales: Lupin
14 November 2008
Lupin acquires majority stake in South Africa's Pharma Dynamics
18 September 2008
Lupin acquires stake in Australian pharma firm Generic Health
21 August 2008
Lupin in marketing alliance with Forest for asthma product
19 August 2008
Lupin Ltd, Sun Pharma and Dr Reddy's get US FDA approval for generic Depakote delayed-release tablets
31 July 2008
Lupin enter Europe with acquisition of German pharma marketing agency Hormosan
30 July 2008
Lupin gets €20 million from patent deal
13 October 2007
Lupin acquires Japan''s Kyowa Pharmaceutical
10 October 2007
Lupin acquires drugs intermediates manufacturer Rubamin Laboratories
28 September 2007
Lupin to invest Rs200 crore in new plant, capacity addition
10 August 2007
Lupin gets DCGI nod for phase II and III clinical trials of herbal psoriasis drug
19 July 2007
Lupin receives tentative US FDA approval for anti-psychotic drug Ziprasidone
21 May 2007
Lupin gets USFDA approval for paediatric Suprax oral suspension
12 April 2007
Lupin sells part rights of 'perindopril' to French firm for Rs115 crore
07 April 2007
Lupin gets marketing approval for cefpodoxime proxetil in France
13 March 2007
Lupin awarded tentative US FDA approval for sertraline
02 January 2007
Lupin gets US FDA approval for Meloxicam
20 July 2006
Lupin to acquire 51-per cent stake in Dafra
25 May 2006
Lupin gets US FDA approval for Cefdinir
24 May 2006
US FDA approves Lupin's cefprozil suspension, Orchid's tablets
20 December 2005
Lupin places $100-million FCCB
07 December 2005
Lupin receives US FDA approval for Cephalexin capsules
01 December 2005
Lupin receives IND approval from DCGI for Desoris LLL-3348
28 November 2005
FIIs hike stake in Lupin, Cadila Healthcare, Aurobindo Pharma
20 October 2003
Lupin to restructure board; to licence out new chemical entity
13 October 2003
Lupin promoter D B Gupta to sell 12.5% stake to Newbridge
10 July 2003
Citigroup to finalise Rs 300-cr equity investment deal in Lupin
09 May 2003
Lupin turns to cephalosporins and cardiovasculars for growth
22 November 1999
 search domain-b